Articles dans des revues avec comité de lecture (42)
25.
Hendlisz, A., Golfinopoulos, V., Deleporte, A., Paesmans, M., Mansy, H. E., Garcia, C., Peeters, M., Annemans, L., Vandeputte, C., Maetens, M. M., Borbath, I., Dresse, D., Houbiers, G., Fried, M., Awada, A., Piccart-Gebhart, M., Van Laethem, J.-L., & Flamen, P. (2013). Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC cancer, 13, 190. doi:10.1186/1471-2407-13-19026.
Maisonobe, J.-A., Garcia, C., Necib, H., Vanderlinden, B., Hendlisz, A., Flamen, P., & Buvat, I. (2013). Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy. European journal of nuclear medicine and molecular imaging, 40(2), 166-174. doi:10.1007/s00259-012-2274-x28.
Buvat, I., Necib, H., Garcia, C., Wagner, A., Vanderlinden, B., Emonts, P., Hendlisz, A., & Flamen, P. (2012). Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer. European journal of nuclear medicine and molecular imaging, 39(10), 1628-1634. doi:10.1007/s00259-012-2172-229.
Hendlisz, A., Golfinopoulos, V., Garcia, C., Covas, A., Emonts, P., Ameye, L., Paesmans, M., Deleporte, A., Machiels, G., Toussaint, E., Vanderlinden, B., Awada, A., Piccart-Gebhart, M., & Flamen, P. (2012). Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy. Annals of oncology, 23(7), 1687-1693. doi:10.1093/annonc/mdr55430.
Berghmans, T., Pasleau, F., Paesmans, M., Bonduelle, Y., Cadranel, J., Toth, C., Garcia, C., Giner, V., Holbrechts, S., Lafitte, J.-J., Lecomte, J., Louviaux, I., Markiewicz, E., Meert, A.-P., Richez, M., Roelandts, M., Scherpereel, A., Tulippe, C., Van Houtte, P., Van Schil, P., Wachters, C., Westeel, V., & Sculier, J.-P. (2012). Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations. The European respiratory journal, 39(1), 9-28.32.
Van Ruychevelt, V., Garcia, C., Meert, A.-P., Berghmans, T., Paesmans, M., Flamen, P., & Sculier, J.-P. (2011). Tomographie par émission de positons au 18F-FDG et réponse anticancéreuse. Détermination de la réponse à la chimiothérapie de première ligne des cancers bronchiques non à petites cellules avancés: critères métaboliques ou morphologiques? Revue des maladies respiratoires, 28(5), 618-625. doi:10.1016/j.rmr.2011.03.00433.
Necib, H., Garcia, C., Wagner, A., Vanderlinden, B., Emonts, P., Hendlisz, A., Flamen, P., & Buvat, I. (2011). Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging. The Journal of nuclear medicine, 52(3), 354-361. doi:10.2967/jnumed.110.08015034.
Terrones Munoz, V., Garcia, C., Flamen, P., Meert, A.-P., CsToth, I., Sculier, J.-P., & Berghmans, T. (2011). La glycolyse lésionnelle totale et le volume métabolique en 18 FDG TEP TDM: deux nouveaux facteurs pronostiques dans le cancer bronchique non à petites cellules. Revue des maladies respiratoires, 28.35.
Paesmans, M., Wong, C., Patz, E., Komaki, R., Eshmann, S., Govidan, R., Van Steekiste, J., Meert, A.-P., de Jong, W., Higashi, K., Borst, G., Van Baardwyk, A., Ameye, L., Lafitte, J.-J., Berghmans, T., Garcia, C., Flament, P., Flamen, P., Rami Porta, R., & Sculier, J.-P. (2011). Is primary tumour standardizeds uptake volume (SUV) an independent prognostic factor for NSCLC? The European respiratory journal.